Downregulation of insulin receptors in obese man
- PMID: 437366
- DOI: 10.2337/diab.28.4.287
Downregulation of insulin receptors in obese man
Abstract
In an attempt to determine whether the decreased number of insulin's receptors in obesity is a result of downregulation of the receptors, diazoxide (5 mg/kg/d) was given to 10 obese subjects. Insulin's suppression by diazoxide in these 10 subjects resulted in a mild glucose intolerance and an increase in insulin's receptors in seven of the 10 subjects. The subjects could be divided into three groups by analyzing the Scatchard plots of their insulin receptor studies before and after diazoxide. Four subjects exhibited an increase in both high affinity and low affinity receptors, three showed an increase only in high affinity receptors, and three failed to demonstrate any change in receptors in response to diazoxide. These studies support the concept that the decreased number of insulin's receptors observed in obesity is a result of the downregulation of the receptors and is not the primary, underlying cause of insulin resistance in obesity, although a contributory role cannot be ruled out.
Similar articles
-
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.J Clin Invest. 1980 Jun;65(6):1272-84. doi: 10.1172/JCI109790. J Clin Invest. 1980. PMID: 6997333 Free PMC article.
-
Role of insulin receptors in obesity-related diabetes.Horm Metab Res. 1982 Dec;14(12):623-6. doi: 10.1055/s-2007-1019102. Horm Metab Res. 1982. PMID: 6759356
-
Modification of insulin resistance by diazoxide in obese Zucker rats.Endocrinology. 1993 Aug;133(2):705-12. doi: 10.1210/endo.133.2.8344209. Endocrinology. 1993. PMID: 8344209
-
Active role for the vasculature in the delivery of insulin to skeletal muscle.Clin Exp Pharmacol Physiol. 2005 Apr;32(4):302-7. doi: 10.1111/j.1440-1681.2005.04188.x. Clin Exp Pharmacol Physiol. 2005. PMID: 15810996 Review.
-
The molecular mechanism of insulin action.Annu Rev Med. 1985;36:429-51. doi: 10.1146/annurev.me.36.020185.002241. Annu Rev Med. 1985. PMID: 2986528 Review.
Cited by
-
Insulin Clearance in Obesity and Type 2 Diabetes.Int J Mol Sci. 2022 Jan 6;23(2):596. doi: 10.3390/ijms23020596. Int J Mol Sci. 2022. PMID: 35054781 Free PMC article. Review.
-
The Potential Role of Activating the ATP-Sensitive Potassium Channel in the Treatment of Hyperphagic Obesity.Genes (Basel). 2020 Apr 21;11(4):450. doi: 10.3390/genes11040450. Genes (Basel). 2020. PMID: 32326226 Free PMC article. Review.
-
GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity.JCI Insight. 2020 Jun 4;5(11):e136283. doi: 10.1172/jci.insight.136283. JCI Insight. 2020. PMID: 32369454 Free PMC article.
-
Separation of physiological factors influencing glucose-insulin kinetics in diabetic patients.Ann Biomed Eng. 1985;13(2):195-213. doi: 10.1007/BF02584238. Ann Biomed Eng. 1985. PMID: 3890627
-
Reduced insulin removal and erythrocyte insulin binding in obese children.Eur J Pediatr. 1988 Dec;148(3):233-7. doi: 10.1007/BF00441410. Eur J Pediatr. 1988. PMID: 3063531
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources